Clinical Trials Logo

Abortion, Missed clinical trials

View clinical trials related to Abortion, Missed.

Filter by:

NCT ID: NCT06469203 Not yet recruiting - Missed Abortion Clinical Trials

Oxytocin Effectiveness in First Trimester Dilatation and Curettage - a Double Blind Placebo Controlled Randomized Trial

Start date: June 2024
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the impact of oxytocin on perioperative blood loss during the D&C procedure, as well as to assess early and late complications associated with it's use.

NCT ID: NCT05516810 Active, not recruiting - Missed Abortion Clinical Trials

The Accuracy of Ultrasound Diagnosis of Hydatidiform Moles

Start date: October 19, 2021
Phase:
Study type: Observational

This is a prospective observational study assessing which ultrasound findings are best at excluding a molar pregnancy in first trimester miscarriage.

NCT ID: NCT05342467 Recruiting - Missed Abortion Clinical Trials

Gemeprost Versus Dinoprostone in First Trimester Miscarriages

Start date: November 11, 2021
Phase: Phase 2
Study type: Interventional

Comparison between gemeprost and dinoprostone to evacuate first trimester miscarriages.

NCT ID: NCT05216952 Completed - Missed Abortion Clinical Trials

Ulipristal Acetate for Use in Early Pregnancy Loss

Start date: May 11, 2022
Phase: Phase 2
Study type: Interventional

The investigators will study the feasibility of using 90mg ulipristal acetate, a selective progesterone receptor agonist, as an adjunct to 800mcg vaginal misoprostol for the medical management of early pregnancy loss. Patients will be followed to assess effective treatment of early pregnancy loss, additional interventions needed, side effects, adverse events and patient acceptability.

NCT ID: NCT05124314 Recruiting - Abortion, Missed Clinical Trials

Comparison of Two Different Drug Regimens for Medical Treatment of Early Pregnancy Loss

Start date: October 27, 2021
Phase: Phase 4
Study type: Interventional

The purpose of this study is to compare the safety and efficacy of a combination of two drugs (mifepristone and misoprostol) to only one of these drugs (misoprostol) in medical management of missed miscarriage up to 13+6 weeks of pregnancy (early pregnancy loss). The investigators aim to enroll 220 patients within two years which would be enough to determine the difference between these two treatments with confidence.

NCT ID: NCT05103098 Not yet recruiting - Miscarriage Clinical Trials

Sublingual Misoprostol In Medical Treatment of First Trimester Missed Miscarriage

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The aim of this work is to compare the effectiveness of sublingual misoprostol 400 mcg versus 800 mcg for medical treatment of the first trimester missed miscarriage.

NCT ID: NCT05094375 Not yet recruiting - Miscarriage Clinical Trials

Vaginal Misoprostol In Medical Treatment of First Trimester Missed Miscarriage

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

Efficacy of vaginal misoprostol 600 Mg versus 800 Mg in termination of the first trimester missed abortion were assist

NCT ID: NCT05088707 Not yet recruiting - Miscarriage Clinical Trials

Sublingual Versus Vaginal Misoprostol In Medical Treatment of Second Trimestric Missed Miscarriage

Start date: November 1, 2021
Phase: N/A
Study type: Interventional

The aim of this work is to compare the effectiveness of vaginal versus sub-lingual misoprostol for medical treatment of the second trimester missed miscarriage

NCT ID: NCT05001061 Not yet recruiting - Missed Abortion Clinical Trials

Sublingual vs Vaginal Misoprostol for Termination of First Trimesteric Missed Abortion

Start date: August 3, 2021
Phase: Early Phase 1
Study type: Interventional

Efficacy of sublingual versus vaginal misoprostol in termination of first trimester missed abortion

NCT ID: NCT04989400 Completed - Clinical trials for Induction of Second Trimester Abortion

Use of Ulipristal Acetate in Induction of Second Trimester Missed Abortion

Start date: January 1, 2019
Phase: Phase 4
Study type: Interventional

The aim of this work is to assess the effectiveness and safety of Ulipristal Acetate in the management of 2nd trimester missed abortion along with misoprostol in pregnant women with previous caesarean section versus the use of misoprostol only with placebo as regards the time needed for abortion,Hypothesis: In pregnant women with 2nd trimester missed abortion with previous caesarean section , Ulipristal Acetate may decrease the time interval to achieve abortion when combined with Misoprostol in comparison to misoprostol alone.the included women divided to 2 groups Group A: will receive Ulipristal acetate 30mg, starting misoprostol 12 hours later 100µg every 6 hours buccal according to FIGO guidelines 2017.Group B: will receive placebo then 12 hours later start misoprostol 100µg every 6 hours buccal according to FIGO guidelines 2017. then we assess Induction-to-abortion interval time.